The QualityStocks Daily Friday, March 20th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (GAXY) +437.50%

StockMarketWatch (BLPH) +430.97%

SmallCapRelations (NBDR) +48.15%

The QualityStocks Daily Stock List

AeroGrow International, Inc. (AERO)

Investor Village, Zacks, hot Stocked, Awesome Penny Stocks, StockInvest.us, New Cannabis Ventures, Stockwatch, TMXmoney, Daily Marijuana Observer, Market Screener, Stockhouse, last10k, Investing Daily, Stockopedia, Wallet Investor, GlobeNewswire and MacroTrends reported previously on AeroGrow International, Inc. (AERO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AeroGrow International, Inc. engages in the development, marketing, direct-selling, and wholesale of indoor garden systems to consumers and retailers around the world. The OTCQB-listed Company is the manufacturer and distributor of AeroGardens – the world’s leading family of In-Home Garden Systems™. AeroGrow International, Inc. is a subsidiary of SMG Growing Media, Inc. Formed in 2002, AeroGrow International is headquartered in Boulder, Colorado.

AeroGrow International entered into a strategic partnership in 2013 with Scotts Miracle-Gro to continue to expand the indoor gardening market. The Company’s AeroGardens allow anyone to grow farmer’s market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more, indoors, simply and easily. AeroGrow’s main products include indoor gardens and proprietary seed pod kits.

In addition, AeroGrow provides grow lights and a patented nutrient formula. The Company also provides assorted cooking, gardening, and decor accessories. It offers its in-home garden systems under the AeroGardens name. AeroGrow International’s products are used in the gardening, cooking, healthy eating, and home and office décor markets.

With the AeroGarden, plants grow in water five times faster than in soil. No herbicides or pesticides are part of the process. Moreover, AeroGarden grows non-GMO (Genetically Modified Organism) seeds. Customers can grow plants year round.

This past January, AeroGarden, the world’s leading in-home garden system, announced it reimagined its 9-pod Bounty family. Bounty’s new features and finishes require no sun, soil, or outdoor space. The Company states that as many as 40 enhancements enable the new Bounty to nurture bigger, fuller, more productive plants. This is while making them easier than ever to grow. Non-GMO, pre-seeded pods sprout in days, harvest in weeks, and last for months, with a 100 percent germination guarantee.

Last month, AeroGrow International announced results for its Q3 ended December 31, 2019. For the quarter ended December 31, 2019, it recorded Net Revenue of $18.5 million. This represents an increase of 43 percent over the same period in the previous year. Income from Operations was $1.2 million, improved from a loss of $535K in the previous year.

For the nine months ended December 31, 2019, Net Revenue stands at $27.4 million. This represents an increase of 9 percent in comparison to the same period last year. The Company’s Loss from Operations for the nine month period was $918K, up from a loss of $517K the previous year.

AeroGrow International, Inc. (AERO), closed Friday's trading session at $1.30, even for the day, on 11,889 volume with 48 trades. The average volume for the last 3 months is 12,826 and the stock's 52-week low/high is $0.610099971/$2.00.

chart

Allied Esports Entertainment, Inc. (AESE)

Market Chameleon, Venture Beat, TipRanks, Investors Observer, last10k, Street Insider, Morningstar, Stockopedia, ShareInvestor.com, Nasdaq, ETF.com, Business Wire, GuruFocus, Simply Wall St, Seeking Alpha, TradingView, InvestorsHub, ETF Channel, Barchart, and YCharts reported beforehand on Allied Esports Entertainment, Inc. (AESE), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Allied Esports Entertainment, Inc. is a worldwide esports entertainment company listed on the NasdaqGS. It provides unique infrastructure, transformative live experiences, multiplatform content and interactive services to audiences globally via its strategic fusion of two strong entertainment brands: Allied Esports International, Inc. (Allied Esports) and the World Poker Tour (WPT). Incorporated in 2017, Allied Esports Entertainment is based in Irvine, California.

Allied Esports is an award-winning esports enterprise consisting of an international network of dedicated esports properties and content production facilities. Its mission is to connect players, streamers and fans globally through integrated arenas, including its flagship venue, HyperX Esports Arena Las Vegas, its fleet of mobile esports trucks, the HyperX Esports Trucks, and affiliate members of the Allied Esports Property Network that serve as competition battlegrounds and everyday content generation hubs.

World Poker Tour is the premier name in globally televised gaming and entertainment. It has brand presence in land-based tournaments, television, online, as well as mobile. In 2002, WPT sparked the worldwide poker boom with the creation of its iconic television show, now in its 18th season, based on a series of high-stakes poker tournaments. ClubWPT.com is an innovative online membership platform that offers inside access to the WPT.

This month, the WPT® and its partner, partypoker, announced the first WPT Online Series that will take place exclusively on the partypoker platform. The series will take place from May 10-26, 2020. The $3,200 buy-in, $5 million guaranteed WPT Online Championship will highlight the schedule. The WPT Online Championship will occur over the course of the entire festival, with Day 1 flights available starting on May 10.

The entire partypoker series includes $30 million in guarantees and $7 million for the WPT events on the schedule. partypoker.com is one of the oldest, most recognized and trusted online poker brands. Launched in August 2001, partypoker.com is one of the pioneers of the online poker industry.

This week, Allied Esports Entertainment announced its financial results for Q4 and full year ended December 31, 2019, and also an update on a number of important business initiatives. Chief Executive Officer, Mr. Frank Ng, said, "Allied Esports Entertainment wrapped-up a transformational year ending with a strong fourth quarter highlighted by robust topline growth and continued execution of our strategic initiatives. Fourth quarter total revenues of $6.5 million increased 19.5 percent compared to the fourth quarter last year, driven by growth in both our Esports and Poker businesses…we also made significant progress in the fourth quarter with our strategic partnerships announced earlier in the year with Simon Property Group (NYSE: SPG) and TV Azteca and with this momentum, we announced a new relationship with Brookfield Properties…”

Allied Esports Entertainment, Inc. (AESE), closed Friday's trading session at $1.92, up 31.5068%, on 183,477 volume with 903 trades. The average volume for the last 3 months is 68,409 and the stock's 52-week low/high is $0.400000005/$10.8100004.

chart

Journey Energy, Inc. (JRNGF)

Capital Cube, Market Seat, Morningstar, PR Newswire, TipRanks, OTC Markets, Letstock.net, Trade Ideas, Stockwatch, Dividend Investor, MarketBeat, GuruFocus, Dividend.com, Tech Know Bits, Stockhouse, TradingView, Nasdaq, Barchart, Wallet Investor, and Market Screener reported earlier on Journey Energy, Inc. (JRNGF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Journey Energy, Inc. engages in the exploration, development, and production of crude oil and natural gas in the Province of Alberta. Its concentration is on oil-weighted operations in western Canada. The Company formerly went by the name Sword Energy, Inc. It changed its corporate name to Journey Energy, Inc. in July of 2012. Journey Energy has its head office in Calgary, Alberta. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Journey Energy was created out of Sword Energy, Inc. in July of 2012. From November 2012 to December 2013, it acquired Herronton and 10 additional minor acquisitions. Journey Energy has grown from 4,000 BOE/d at (47 percent liquids) to 8,500 BOE/d (49 percent liquids) through organic growth and accretive acquisitions over two years.

Journey Energy’s strategy is to boost its production base by drilling on its existing core lands, implementing waterflood projects, and by executing on accretive acquisitions. The Company looks to optimize its legacy oil pools on existing lands through the application of best practices in horizontal drilling and, where feasible, with water floods. In addition, it is in the early phases of advancing development of an unconventional shale resource play in the oil window of the Duvernay, in the western shale basin of its central core area.

The Company’s expertise in horizontal, multi-frac drilling and secondary recovery methods enables it to profitably acquire and develop large oil-in-place reservoirs fairways. In the Central Region it has (4,800 boe/d; roughly 56 percent oil and NGLs) - Gilby-Duvernay, Crystal, Cherhill.

In the South Region, Journey Energy has (5,200 boe/d; about 38 percent oil and NGLs) - Matziwin, Skiff, Herronton. In the Resource Fairway, it has shallow, low-risk development drilling in conventional oil pools.

This month, Journey Energy announced its 2019 operating and financial results. Selected 2019 highlights include the Duvernay Joint Venture (JV) with Kiwetinohk Resources Corporation (KRC) starting operations with the drilling of three wells. All were then placed on-production during the year. Performance of the wells continues to be in the top tier of wells drilled to date in the East Shale Basin.

The Company states that Journey Energy shareholders will benefit from early development capital expenditures to be incurred by KRC, while Journey retains a 37.5 percent working interest (WI) in this commercial development. The drilling program comprised 7 (7.0 net) development wells all in the Matziwin core area with a 100 percent success rate. Journey Energy produced 9,463 boe/d (49 percent liquids) in Q4 and 9,372 boe/d (48 percent liquids) for the year.

Journey Energy, Inc. (JRNGF), closed Friday's trading session at $0.0694, up 70.936%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 3,349 and the stock's 52-week low/high is $0.037829998/$2.25427007.

chart

H/Cell Energy Corporation (HCCC)

Street Insider, Uptick Newswire, YCharts, Fairly Valued, MarketBeat, Financial Buzz, OTC Markets, 4-Traders, Stockwatch, Stockopedia, Market Wire News, Market Screener, Simply Wall St, Stockhouse, Wallet Investor, Morningstar, Equities and Dividend Investor reported beforehand on H/Cell Energy Corporation (HCCC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

H/Cell Energy Corporation designs and implements clean energy solutions featuring hydrogen and fuel cell technology. The Company is an integrator that focuses on the design and implementation of clean energy solutions including solar, battery, fuel cell and hydrogen generation systems. Via its subsidiaries, it also provides environmental systems and security systems integration. H/Cell Energy is based in Dallas, Texas. The Company lists on the OTC Markets’ OTCQB.

H/Cell Energy serves the residential, commercial, and government sectors. The Company has developed and implemented a hydrogen energy system used to totally power a residence or commercial property with clean energy. This is so it can run independent of the utility grid and also provide energy to the utility grid for monetary credits. The unique system uses renewable energy as its source for hydrogen production.

The design of the HC-1 system is to provide clean energy for a better environment. The system eliminates the electric bill and dependence on fossil fuels. Furthermore, it permits one to benefit with tax and energy credits while helping make the environment safe for future generations. The HC-1 system is totally scalable. Upon installation, the HC-1 system operates as a self-sustaining energy system providing electricity and/or hydrogen fuel for transportation.

The design of each HC-1 system is to accommodate the electrical loads for an end user. The system can be configured to meet any kilowatt hour (kWh) demands. The installation includes solar panels, a hydrogen generator, a fuel cell and a tank, which would be located exterior to the property with the battery system located interior to the property.

This past January, H/Cell Energy announced it was awarded $800k in new contracts for renewable energy, environmental systems and general contracting. The contracts include work to be completed at different locations in the United States and Australia including Queensland Rail, Ergon Energy, Healy State School, Mossman State High School, University of Pennsylvania Health System and Coca Cola.

H/Cell Energy Corporation (HCCC), closed Friday's trading session at $0.1609, even for the day, on 35,236 volume. The average volume for the last 3 months is 2,168 and the stock's 52-week low/high is $0.160899996/$1.60000002.

chart

Indivior PLC (INVVY)

Zacks, Stocktwits, TipRanks, MacroTrends, Street Insider, Investor Place, Investing.com, Morningstar, GlobeNewswire, Market Screener, BioSpace, Dividend Investor, StockInvest.us, PR Newswire, GuruFocus, Business Wire, Stockhouse, Nasdaq, YCharts, Dividend.com, Seeking Alpha, Wallet Investor, Stockwatch and Barchart reported earlier on Indivior PLC (INVVY), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Indivior PLC is an international pharmaceutical company based in North Chesterfield, Virginia. It is working to help change patients' lives through developing medicines to treat addiction and serious mental illnesses. The Company’s vision is that all patients globally will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Incorporated in 2014, Indivior lists on the OTC Markets.

The Company employs greater than 800 individuals worldwide. Its portfolio of products is available in more than 40 countries worldwide. Indivior’s commitment is to transforming addiction from a worldwide human crisis to a recognized and treated chronic disease.

The Company (building on its international portfolio of opioid dependence treatments) has a pipeline of product candidates. The design of these products is to expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction. This includes alcohol use disorder.

Additionally, Indivior markets medicine for the treatment of schizophrenia in adults in the United States. The Company also has a licensing agreement to bring this treatment to patients suffering from schizophrenia in Canada.

Indivior products available to U.S. Healthcare Providers and Patients include SUBLOCADE™ (buprenorphine extended-release) injection for subcutaneous use (CIII); SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII); and PERSERIS™ (risperidone) for extended-release injectable suspension. The Company sells legacy products such as Temgesic, Buprex and Buprenex in different countries outside the United States.

This past December, Indivior announced a new research collaboration with Virginia Tech extending the RECOVER (Remission from Chronic Opioid Use-Studying Environmental and Socio-Economic Factors on Recovery) Study ™. RECOVER is a multisite, non-interventional cohort study examining long-term recovery in individuals with moderate to severe opioid use disorder who received at least one dose of study treatment during the SUBLOCADE Phase 3 clinical trials (NCT02357901 and NCT02510014).

The study design and participant characteristics of the RECOVER study can be found in Contemporary Clinical Trials. The study will be led by a team of researchers at the Fralin Biomedical Research Institute at Virginia Tech Carilion.

Indivior PLC (INVVY), closed Friday's trading session at $3.00, up 34.5291%, on 28,476 volume with 113 trades. The average volume for the last 3 months is 17,439 and the stock's 52-week low/high is $1.97500002/$7.13999986.

chart

Medicine Man Technologies, Inc. (MDCL)

Street Insider, MJ PurePlay Index, Penny Stock Tweets, YCharts, New Cannabis Ventures, Investing Daily, Stockhouse, Technical420, Green Market Report, Cannabis Life Network, Uptick Newswire, MarketWatch, The Street, Daily Marijuana Observer, Morningstar, Barchart, Insider Financial, Simply Wall St, GuruFocus, PR Newswire, MarketBeat and Stock Day Media reported previously on Medicine Man Technologies, Inc. (MDCL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Medicine Man Technologies, Inc. is a vertically integrated cannabis operator. The OTCQX-listed Company provides consulting, cultivation supplies and equipment, retail pharma-grade products, and turnkey solutions for cannabis producers, processors, and retailers. The Company is leveraging its considerable expertise and intellectual property (IP) to vertically integrate into plant-touching cannabis operations. Established in 2014, Medicine Man Technologies is headquartered in Denver, Colorado.

In essence, Medicine Man Technologies is taking advantage of its knowledge and IP to vertically integrate retail, cultivation, formulation and distribution operations. Its client portfolio includes active and past clients in 20 States and seven countries.

The Company started 2019 with announcing the pending revenue positive acquisitions of Medicine Man Denver and MedPharm. Futurevision Ltd. (dba Medicine Man Denver) is a profitable operator and is a well-known industry leader in the cannabis business in the State of Colorado and has a large cultivation facility. MedPharm is a fast-growing revenue positive pharmaceutical-grade cannabis operator. It cultivates, processes, as well as formulates to pharmaceutical standards for medical and recreational users.

Medicine Man Technologies’ IP includes the ""Three A Light"" methodology for cannabis cultivation and pending acquisition candidate MedPharm's GMP-certified facility. This facility has the first cannabis research license to conduct clinical trials in the USA.

Medicine Man Technologies has entered into agreements with 11 premier cannabis operators throughout Colorado to become one of the largest vertically integrated seed-to-sale operators in the worldwide cannabis industry. Upon closing the series of pending acquisitions, expected to take place this year, the Company will have 13 cultivation operations, five product manufacturing operations, 34 dispensaries, and product development and innovation all under a single entity.

This month, Medicine Man Technologies announced that the Marijuana Enforcement Division (MED), a division of the Colorado Department of Revenue, approved the Company’s application for suitability. In 2019, the Colorado legislature passed, and the Governor signed House Bill 19-1090 that allowed publicly traded companies to own Colorado cannabis licenses.

Shortly after HB19-1090 went into effect, Medicine Man Technologies submitted a suitability application to start the process of executing against its outlined acquisition strategy. The design of this thorough State-mandated review is to ensure that Medicine Man Technologies and its officers are suitable to run an above-board and compliant cannabis company.

This week, Medicine Man Technologies announced that Nirup Krishnamurthy has joined the Company as Chief Integration and Information Officer, reporting directly to Justin Dye, Chief Executive Officer. In this newly created role, Krishnamurthy will lead the integration of Medicine Man Technologies’ outlined acquisitions, any future acquisitions and the realization of identified integration synergies. Further to integration responsibilities, Krishnamurthy will lead the Company’s IT strategy and operations, implementing business solutions to empower real-time, data-driven decisions and ensure the security and stability of Medicine Man’s infrastructure.

Medicine Man Technologies, Inc. (MDCL), closed Friday's trading session at $1.235, off by 3.5156%, on 90,671 volume with 140 trades. The average volume for the last 3 months is 86,381 and the stock's 52-week low/high is $1.04999995/$4.17000007.

chart

Moneta Porcupine Mines, Inc. (MPUCF)

Small Cap Power, Resource World, Junior Mining Network, Northern Miner, 24hgold, Dividata, TradingView, YCharts, Mining News Feed, InvestorsHub, GuruFocus, Wallet Investor, Mining Stock Valuator, Gold Stock Data, Pink Investing, Investing.com, Seeking Alpha, Nasdaq, InvestorX and Stockhouse reported earlier on Moneta Porcupine Mines, Inc. (MPUCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Moneta Porcupine Mines, Inc. operates as a mineral resource exploration and development company in Canada. It explores for gold, copper, nickel, and zinc deposits. The Company holds a 100 percent interest in 6 core gold projects strategically located along the Destor-Porcupine Fault Zone in the Timmins Gold Camp with greater than 85 million ounces of past gold production. The projects consist of the Golden Highway, North Tisdale, Nighthawk Lake, DeSantis East, Kayorum and Denton projects. Moneta Porcupine Mines is based in Timmins, Ontario and the Company lists on the OTC Markets.

The Company’s flagship asset is the Golden Highway Project. Moneta states that the Golden Highway Project is set for consolidation and gold discoveries because of its experienced management team with a successful track record, and the Golden Highway camp already comprises 10Moz with adjacent gold deposits. Furthermore, it has regional scale potential and an exploration agreement with Wahgoshig First Nations. In addition, Golden Highway has first-rate neighbors, including Goldcorp, McEwen Mining, Pan American Silver, Osisko Mining, and Kirkland Lake Gold.

The Golden Highway Project covers 12 kilometers of prospective ground along the DPFZ of which 4 km hosts the current 43-101 mineral resource estimate consisting of an indicated resource of 556,500 ounces gold contained within 3.82 Mt @ 4.53 g/t Au and a total of 1,174,000 ounces gold contained within 8.47 Mt @ 4.31 g/t Au in the inferred category at a 3.00 g/t Au cut-off.

In February, Moneta Porcupine Mines announced results from five drill holes testing the southern extensions of gold mineralization on the Windjammer South deposit beyond the updated November 2019 NI 43-101 mineral resource estimate. The drilling is part of the expanded 2019/2020 winter drill program now taking place on Moneta's Golden Highway Project, 110 km east of Timmins, Ontario.

Mr. Gary O'Connor , Chief Executive Officer & Chief Geologist, said, "We are pleased to have intersected gold mineralization in large step-outs to the south and west at Windjammer South. Gold mineralization has been intersected in multiple zones over large combined thicknesses up to 400 m south of the BIF. The drill program has successfully confirmed the extensions of gold mineralization with significant step-outs west and east of the updated November 2019 Resource Estimate and has now extended mineralization to the south…”

Moreover, in February, Moneta Porcupine Mines announced the results from three additional drill holes testing the extensions of gold mineralization at the new Westaway Target and the West Block deposit situated outside of the updated November 2019 NI 43-101 mineral resource estimate. These drill holes are also part of the recently expanded 2019/2020 winter drill program now taking place on its Golden Highway Project. Drilling confirmed and extended the 12 new gold mineralized veins discovered at the new Westaway Target and three new gold mineralized veins discovered at West Block.

Moneta Porcupine Mines, Inc. (MPUCF), closed Friday's trading session at $0.0542, up 13.1524%, on 100 volume with 1 trade. The average volume for the last 3 months is 36,547 and the stock's 52-week low/high is $0.0414/$0.108999997.

chart

Apple Rush Company, Inc. (APRU)

Wall Street Analyzer, TipRanks, Market Wire News, Stockwatch, Wallet Investor, Penny Stock Base, Stockhouse, Morningstar, Investing.com, GlobeNewswire, MarketPlace.org, Financial Buzz, MarketWatch, InvestorsHub, and Investors Hangout reported beforehand on Apple Rush Company, Inc. (APRU), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Apple Rush Company, Inc., through its subsidiary APRU, LLC, is a distributor of CPG (Consumer Packaged Goods )products under the trademarked Apple Rush brand and other labels. The Apple Rush brand has more than 40 years of existence in the natural beverage industry. The Company develops, bottles, markets, distributes, and sells diverse beverages and snacks to wholesale and retail clients in the United States. Established in 1998, Apple Rush Company lists on the OTC Markets.

Apple Rush offers organic sparkling juice blended beverages, with apple juice as the base under the brand name Apple Rush. The Company is an historical leader in the organic and natural beverage sector. Its goal is to also become the leader in the distribution of anhydrous hemp oil products nationwide.

Subsidiary APRU, LLC focuses on the development and sales of all natural Apple Rush sparkling juices, and research and development (R&D) of premium hemp extracts, which contain a broad spectrum of cannabinoids and natural hemp derivatives and other active ingredients including the Company’s exclusive agathos active, kratom, kava, blue lotus, and ginseng.

Recently, the Apple Rush Company announced the signing of a private label/white label agreement with UFO Labs.

Mr. Tony Torgerud, Chief Executive Officer of Apple Rush, said, “We have spent a lot of time focusing on the basics of the business, cleaning up our corporate structure, adding additional staff and advisors, planning a National rollout of Apple Rush, and expanding our distribution of some of our key nutraceutical products. Partnering with Art and UFO Labs in this private label program has been a great opportunity for us to prove that our unique cold process chew is accepted within the health and fitness market. We have specially formulated their CBD and caffeine chew with 25mg of CBD and 100mg of caffeine for an exceptional workout product…”

Apple Rush Company, Inc. (APRU), closed Friday's trading session at $0.0017, up 70.00%, on 13,365,401 volume with 190 trades. The average volume for the last 3 months is 4,818,340 and the stock's 52-week low/high is $0.00095/$0.024.

chart

Comepay, Inc. (CMPY)

InvestorsHub, Business Insider, and Nasdaq reported on Comepay, Inc. (CMPY), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Comepay, Inc. provides Internet acquiring and support services. In addition, the Company engages in facilitating instant payments and internet based payment transactions via kiosks, mobile interfaces, and Web-based applications. The Comepay group of companies includes Comepay, RP Systems, M-NN LLC, and Chek-Online. Comepay has its corporate headquarters in Vaughan, Ontario.

The Company also leases and sells cash registers and point of sale (POS) systems. This includes its recently developed proprietary multifunctional smart POS fiscal cash register system. Comepay processes more than 4.7 million customer payments monthly. At present, the Company has greater than 12,700 kiosks throughout Russia.

The above-mentioned companies are now concentrating their planned business expansion on the smart POS fiscal cash register system "Cassatka". This is to help businesses comply with Russian taxation legislation, 54-FZ, that required 1.2 million businesses in fiscal 2018, and a further 1.4 million businesses in fiscal 2019 to install new, federally compliant on-line cash registers.

The Cassatka is Comepay's multifunctional smart POS online fiscal cash register. Cassatka can process payments and meet fiscal data storage requirements for participating businesses. Cassatka is a convenient and cost competitive solution for businesses to meet the new federal taxation requirements in Russia.

As the companies expand their business model, Comepay expects to offer blockchain acquiring services and to accept payments in numerous crypto currencies on the Cassatka. The Comepay group of companies currently earn revenue from an array of channels. These include fee-based commissions on payment processing for cash and debit card payments, software licensing, kiosk placement fees and other rental fees for cash registers and associated equipment.

This past February, Comepay announced that its wholly-owned subsidiary, Chek-Online LLC, again added more functionality to its smart terminals through integrating merchant acquiring services from two large banks in Russia for its versatile handheld Cassatka-Mini terminal. Chek-Online is a foremost manufacturer of fiscal cash registers in Russia, and the developer of the family of Cassatka smart terminals.

Chek-Online plans to expand to several more partner banks for trade acquiring for its Cassatka-Mini Smart terminal. Nonetheless, the integration process has already been launched with two large banks based in Russia, VTB Bank and Otkritie FC Bank.

In April, Comepay announced that Chek-Online concluded an agreement with the National Payment Card System (NSPK) for the use of contactless payment system “Mir” for the Cassatka Mini series of smart terminals. NSPK is the operator of the Russian national contactless payment system “Mir”. NSPK recently concluded an agreement with Chek-Online for the supply of materials required to develop customized solutions for the Cassatka Mini mobile smart terminal. This include contactless payments.

Comepay, Inc. (CMPY), closed Friday's trading session at $0.048, up 54.8387%, on 34,000 volume with 8 trades. The average volume for the last 3 months is 11,175 and the stock's 52-week low/high is $0.070699997/$5.00.

chart

Galaxy Next Generation, Inc. (GAXY)

Simply Wall St, Wallet Investor, Dividend Investor, GuruFocus, GlobeNewswire, Teletrader, Market Screener, Modest Money, Barchart, The Street, Investors Hangout, Corporate Information, Last10k, MarketWatch, and Street Insider reported on Galaxy Next Generation, Inc. (GAXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Galaxy Next Generation, Inc. (GAXY) is a U.S. distributor of interactive learning technology hardware and software, which create totally collaborative instructional environments. The Company’s products include its own private-label interactive touch screen panel and many other national and international branded peripheral and communication devices. Galaxy Next Generation has its corporate headquarters in Toccoa, Georgia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Galaxy Next Generation’s distribution channel includes more than 22 resellers across the United States. These resellers mainly sell the Company’s products within the commercial and educational market. Typically, the K-12 education market is the largest customer base for Galaxy Next Generation products. This market comprises close to 90 percent of the Company's sales.

The Company works together with educators to help them develop teaching and learning in their Connected Classrooms. This new approach takes advantage of digital content, learning data, and one-of-a-kind technologies to create an immersive and interactive experience.

Galaxy’s products include interactive panels, collaboration devices, panel accessories, and integrated PCs. The Company’s software includes Ximbus and Oktopus. In addition, Galaxy offers an assortment of on-site training opportunities. The Company also focuses on premier after sales services.

In March, Galaxy Next Generation announced a new product offering where it has started to use online training resources for its products and customers. Mr. Gary LeCroy, Galaxy Next Generation’s Chief Executive Officer, said, “We now have reference cards available for the software and hardware, step by step instructions on using the software and hardware, and we are even offering onsite training at the customers school or place of business as part of their purchase.”

Furthermore, in March, Galaxy Next Generation announced that Newton County, Georgia, School District, a prior purchaser of G2 panels, will continue to purchase the Company’s G2 panel as a standard. Mr. LeCroy said, "We are excited to be the official company awarded Newton County School District’s G2 panel contract. It is always edifying to have an existing customer see the continued value of our products.”

Galaxy Next Generation, Inc. (GAXY), closed Friday's trading session at $0.043, up 437.5%, on 71,492,935 volume with 2,615 trades. The average volume for the last 3 months is 1,022,361 and the stock's 52-week low/high is $0.0051/$2.98000001.

chart

Biostage, Inc. (BSTG)

Stock Twits, Stockhouse, Zacks, MarketWatch, InvestorsHub, InvestorPoint, Stock News Journal, Simply Wall St, Business Insider, GuruFocus, Barchart, The Street, Stock News Gazette, Morningstar, last10k, and AllStockNews reported earlier on Biostage, Inc. (BSTG), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Biostage, Inc. is a biotechnology company listed on the OTC Markets Group’s OTCQB. It is developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea. The Company previously went by the name Harvard Apparatus Regenerative Technology, Inc. It changed its name to Biostage, Inc. in March of 2016. Biostage has its head office in Holliston, Massachusetts.

The Company is developing bioengineered organ implants based on its Cellframe™ technology. This technology combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants.

Based on its preclinical data, Biostage has selected life-threatening conditions of the esophagus as the first clinical application of its technology. Cellspan implants are undergoing development to treat life-threatening conditions of the esophagus, bronchus or trachea with the hope of significantly improving the treatment model for patients.

The basis of Biostage’s Cellframe technology is on more than 20 years of scientific progress in the fields of tissue engineering, cell biology, as well as material science. Cellframe technology combines the best attributes of a synthetic scaffold with tissue engineering and cell biology. The Company’s novel Cellframe™ technology is engineered to stimulate the body’s signaling pathways and natural healing process to regenerate and restore organ function.

During Q3 2018, Biostage advanced its operating programs targeted at bringing its potentially life-changing Cellframe™ technology to underserved patient populations. During the quarter, Biostage completed Phase I of a Fast-Track SBIR grant for $225,000 to develop its Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients. Moreover, the Company progressed on all three cohorts of its pre-clinical piglet studies for the treatment of esophageal atresia being conducted in collaboration with Connecticut Children's Medical Center.

Furthermore, Biostage submitted a follow-up package to the U.S. Food and Drug Administration (FDA) summarizing three additional Good Laboratory Practice (GLP) preclinical studies and an FDA approved first-in-human use of the Company’s Cellspan esophageal implant in support of its Investigational New Drug (IND) filing now targeted for mid-year 2019. Biostage also established advisory relationships with five new clinical experts for current standard-of-care insight and clinical protocol benefit risk assessment. This scientific and clinical feedback endorse its technology platform.

This past November, Biostage announced that Mr. Matthew Dallas and Mr. Jeffrey Young were appointed to its Board of Directors, effective November 6, 2018. Mr. Dallas brings greater than 20 years of financial management experience. This includes 18 years in the life sciences industry. He is presently the Chief Financial Officer (CFO) of AVEO Oncology. Mr. Young also brings greater than 20 years of finance, capital markets, and financial operations experience in the life sciences sector. He is currently the CFO of Axial Biotherapeutics.

Biostage, Inc. (BSTG), closed Friday's trading session at $3.9999, up 55.0349%, on 21,004 volume with 56 trades. The average volume for the last 3 months is 3,606 and the stock's 52-week low/high is $0.75/$4.88000011.

chart

AEON Global Health Corp. (AGHC)

Amigo Bulls, Stock Target Advisor, Stockopedia, Investors Hangout, Penny Stock Hub, Stockwatch, Simply Wall St, Zacks, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stockflare, and Dividend Investor reported on AEON Global Health Corp. (AGHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AEON Global Health Corp., together with its subsidiaries, provides a variety of clinical laboratory testing services in the United States. The Company provides diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, as well as Health Technology Applications. AEON formerly went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. in January 2018. OTCQB-listed, AEON Global Health has its corporate office in Gainesville, Georgia.

The Company is the fastest growing clinical lab and healthcare services organization in the United States. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results. AEON’s chief business focus is providing a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information.

AEON is an innovator in the genomic testing area. The Company has an extensive menu of genetic tests and a pipeline of additional molecular-based tests in development. It provides post contract customer support services. The design of AEON’s Telehealth Solutions is to improve outcomes and reduce hospital readmission through helping clinicians closely monitor patients with chronic illnesses. These include CHF, COPD and Diabetes.

Concerning Toxicology Testing, AEON Global Health provides accurate and fast quantitative testing of drug metabolite levels in urine and oral fluids. The Company’s testing covers more than 80 analytes and metabolites. Its HPLC-tandem mass spectrometry can analyze wider molecular weight and polarity ranges of analytes, providing better selectivity and sensitivity.

AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface. Inscrybe® enables physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or via electronic fax instead of transferring paper.

In May 2018, AEON Global Health announced it earned The Joint Commission’s Gold Seal of Approval® for Laboratory Services Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval is a symbol of quality, which reflects an organization’s commitment to providing safe and effective patient care.

AEON Global Health underwent a thorough onsite survey earlier in 2018. During the review, a Joint Commission expert surveyor evaluated compliance with laboratory standards related to a number of areas. This included document and process control, healthcare-associated conditions, risk reduction, as well as staff qualifications and competency. Additionally, the surveyor conducted onsite observations and interviews.

AEON Global Health Corp. (AGHC), closed Friday's trading session at $0.089, up 242.3077%, on 14,205 volume with 5 trades. The average volume for the last 3 months is 13,637 and the stock's 52-week low/high is $0.0225/$0.363999992.

chart

Zenosense, Inc. (ZENO)

Tip.us, OTC Markets Group, StreetAuthority Financial, Investors Alley, Greenbackers, SmallCapNetwork, MicroCap Gems, Investor Spec Sheet, Wall Street Daily, PennyStocks24, Insider Wealth Alert, The Trading Report, TopStockAnalysts, ProfitableTrading, Pumps and Dumps, DSR News, Wyatt Investment Research, YOLOTraderAlerts, MyBestStockAlerts, PremiereStockAlerts, Dividend Opportunities, and Trade of the Week reported previously on Zenosense, Inc. (ZENO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Zenosense, Inc. is a healthcare technology company headquartered in Valencia, Spain. Its MIDS Medical Ltd. is based in Daresbury, United Kingdom (UK). Zenosense participates in the development of transformational medical diagnostic technologies. These are hand-held devices used at the Point of Care (POC) replacing slow and costly laboratory testing. The Company’s main emphasis, via its joint venture (JV) in MIDS Medical, is the development and commercialization of MIDS Cardiac™. Zenosense lists on the OTC Markets’ OTCQB.

The Company primarily focuses on the development and commercialization of MIDS Cardiac™. This is a POC handheld device for the early detection of certain cardiac event biomarkers to considerably speed up the triage, diagnosis, treatment, and disposition of patients reporting chest pain and with suspected acute myocardial infarction (heart attack). MIDS Cardiac™ is undergoing development for use at the POC for the fast testing of cardiac markers delivering results equal or superior to laboratory gold standard accuracy within minutes.

The MIDS patented technology utilizes a tailored optical sensor like other devices. In addition, it utilzes miniaturized, highly sensitive custom built “Hall Effect” magnetic sensors embedded within a test strip as a Lab-On-Chip device. MIDS has strong patent protection. The MIDS technology platform (under license) is protected by patent applications. The intention of MIDS Cardiac™ is to perform high sensitivity troponin assays at the POC, utilizing a Magnetic Immunoassay Detection System (MIDS technology), an intellectual property (IP) used under license and undergoing further development by MIDS Medical.

Recently, Zenosense announced that its MIDS Medical Ltd. JV (MML) entered a staged funding for the next phase of development of MIDS Cardiac. On August 31, 2018, MML entered into an agreement with a third party investor for financing of up to a total amount of $1,200,000. The expectation is that this funding will cover the costs of the next important development phase of the MIDS Cardiac microfluidic test strip that aims to embody a high sensitivity (HS) troponin assay or an alike assay to prove the MIDS system on a live test.

With this Agreement, MML will receive an initial total amount of $300,000 in exchange for ordinary shares in MML, representing a 2.91 percent equity ownership, with the option to make scheduled payments up to an additional $900,000. The full $1,200,000 investment would equate to a final 10.31 percent equity ownership in MML.

At the beginning of October, Zenosense announced that its MIDS Medical Ltd. JV, MML, expanded its technical team to support the next phase of development of MIDS Cardiac. Following its recent funding agreement, MML arranged the services of three important contractors for its next phase of MIDS development. The design of these contracting arrangements is to efficiently obtain services as and when required by MML.

Zenosense, Inc. (ZENO), closed Friday's trading session at $0.0327, up 63.50%, on 20,073 volume with 8 trades. The average volume for the last 3 months is 39,555 and the stock's 52-week low/high is $0.014999999/$0.159899994.

chart

A.I.S. Resources Limited (AISSF)

PennyStockProfessor,  SMS Penny Picks, DSR News,  eliteotc.com, Wall Street Beauties, WINNINGOTC,  BestDamnPennyStocks,  PennyPickAlerts,  TheNextBigTrade, Stock Commander, Fortune Stock Alerts, and  Penny Stock Hub reported earlier on A.I.S. Resources Limited (AISSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, A.I.S. Resources Limited established in 1967. The Company is managed by experienced, highly qualified professionals who have a long record of accomplishment of success in lithium exploration, production and capital markets. They identify and develop early stage projects globally that have strong potential for growth. A.I.S. Resources has its head office in Nassau, Bahamas. The Company also has a Canadian office in Vancouver, British Columbia.

A.I.S. Resources concentrates on developing significant lithium resource projects in Argentina’s world-renowned Lithium Triangle. The Company has two large projects, Chiron and Guayatayoc. The Chiron Project is 2,732 Ha. The Guayatayoc Project is 5,225 Ha. A.I.S. Resources also has its Vilama Project in the Lithium Triangle. Vilama is 2,500 Ha.

Guayatayoc is an approved borate mine. It encompasses all industrial minerals including lithium. Guayatayoc and Guayatayoc III are in Jujuy Province, 5 kilometers from the town of Abralaite in the Puna plateau. This property encompasses about 5,000 hectares of the Guayatayoc Salar that hosts favorable geology for lithium and boron, positioned adjacent to the El Aguillar mountain range, the source of lithium and boron.

The Chiron Project comprises four concessions in the Salar de Quirón in the Province of Salta, roughly 10 kilometers from the township of Pocitos. Very encouraging results from other, close by, explorers classifies the Chiron Project as having considerable prospectivity.

Recently, A.I.S. Resources Limited announced it was granted an exploration license for seismic and drilling at its Chiron project. This allows A.I.S to quickly progress to a TEM seismic program and then drilling immediately thereafter.

The Company entered into a contract with Quantec Geoscience Argentina S.A. to conduct a 19 point TEM (VES) seismic survey in early January 2018. This work will be completed by February 2018. Preliminary tenders have been received from several drilling companies for an eight hole program of 3,200 meters.

A.I.S. Resources also recently announced that seismic testing detected three distinct aquifers over a wide-ranging region at its Chiron Project in the Pocitos Salar, Salta Province, Argentina.

Mr. Phil Thomas, A.I.S. Resources’ Chief Operating Officer and Exploration Director stated: "This initial seismic data from Chiron based on the TEM geophysics strongly supports our case for acquiring these strategic concessions. Together with our Guayatayoc Project to the northwest in Jujuy province, where we've made excellent progress with our pilot plant production chemistry, A.I.S. is on track for a breakthrough year as an emerging new producer in the lithium brine space in Argentina."

A.I.S. Resources Limited (AISSF), closed Friday's trading session at $0.0301, up 59.2593%, on 20,529 volume with 11 trades. The average volume for the last 3 months is 18,496 and the stock's 52-week low/high is $0.008/$0.094999998.

chart

The QualityStocks Company Corner

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, procurement, and health care platform that offers health care buyers and sellers of pharmaceuticals procurement, currently has more than 11,900 pharmacies as registered users of its proprietary e-commerce platform. Registered users are under no contract of fee obligations when joining the ‘Supplier-to-Pharmacy’ (S2P) trading platform.

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Friday's trading session at $6.25, up 43.3486%, on 547,048 volume with 3,682 trades. The average volume for the last 3 months is 16,296 and the stock's 52-week low/high is $2.0999999/$10.5600004.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, recently announced the opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory (http://cnw.fm/zGUb0). To view the full article, visit http://cnw.fm/A75f1

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Friday's trading session at $1.75, up 31.5789%, on 18,109 volume with 45 trades. The average volume for the last 3 months is 19,298 and the stock's 52-week low/high is $0.600600004/$4.0300002.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang recently announced the launch of a media campaign to raise awareness of the benefits of CBD oil during an interview on “MoneyTV” (http://cnw.fm/gAtd3). To view the full article, visit http://cnw.fm/T7Hdw

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Friday's trading session at $0.12, up 17.6471%, on 72,161 volume with 28 trades. The average volume for the last 3 months is 59,403 and the stock's 52-week low/high is $0.100000001/$0.50999999.

Recent News

chart

Champignon Brands Inc. (CSE: SHRM)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced its intent to commence a normal course issuer bid (“NCIB”) to purchase up to a total of 2,411,883 common shares, representing 5% percent of the issued and outstanding common shares of the company as of March 20, 2020. To view the full press release, visit http://cnw.fm/iwBH5. It’s official, the novel Coronavirus is now a pandemic. The virus first appeared in Wuhan, China at the close of 2019, and as of now, over 180,000 people have been infected. As the virus swept through China, to Europe, the U.S. and finally Africa, one thing has been pretty clear. Things will get worse before they get better, and recognizing that fact, the World Health Organization (WHO) raised the virus’s threat level.

Champignon Brands Inc. (CSE: SHRM) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRM), closed Friday's trading session at $0.29, off by 12.12%, on 1,131,665 volume with 153 trades. The 52-week low/high is $0.275/$0.33.

Recent News

chart

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Bolt Metals Corp. (OTCQB: PCRCF).

Bolt Metals Corp. (CSE: BOLT) (FRANKFURT: NXFE) (OTCQB: PCRCF) (the “Company” or “Bolt Metals”) has completed a debt settlement with three creditors (the "Debt Settlement").  The Debt Settlement will result in an aggregate of $300,000.00 of indebtedness being retired in consideration for the issuance of 999,999 common shares at a price of $0.30 per common share.  The indebtedness is held by three arm’s length parties.  The Debt Settlement is subject to Canadian Securities Exchange approval.

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade battery metals deposits within the Asia-Pacific region, employing a vertically integrated “minerals-to-market” strategy to leverage these assets to their fullest.

Bolt Metals Corp. is advancing its flagship, 100% controlled Cyclops Nickel-Cobalt located in Papua Province, Indonesia with a mandate to become a key contributor to Asia-Pacific’s rapidly expanding electric vehicle and battery supply chain.

The Cyclops project, uniquely positioned within the world’s largest producer of nickel and in proximity to China, the world’s largest “Gigafactory”, features near surface, strong nickel-cobalt mineralization. The property is situated in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Bolt Metals well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to nickel-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Indonesia has recently approved environmental impact studies for factories to produce battery-grade nickel chemicals in Morowali. The approval will allow investors, such as China’s stainless steel giant Tsingshan Group, to continue the construction of their high-pressure acid leaching plants in Morowali, Central Sulawesi.

Ranjeet Sundher, chief executive officer of Bolt Metals, said: “Indonesia continues to make significant strategic decisions, and this latest announcement represents an important step in Bolt Metals’s efforts to benefit from Indonesia’s rapid development as a leading market for all stages of the EV supply chain. With offices in Vancouver, Shanghai and Jakarta, Bolt Metals is well positioned to leverage Asia’s global dominance in the battery manufacturing sector.”

Indonesia’s commitment extends to the very top of government, with Joko Widodo – Indonesia’s President – stating in September 2019 that “for nickel, we want raw materials to be processed in Indonesia. We want added values”. This supports previous pronouncements from key officials, including Indonesian Maritime Minister, Luhut Pandjaitan who remarked that Indonesia will “become the main player in lithium batteries” and that it will “control the world market”.

The country, which is the world’s top nickel ore exporter, has stopped export of unprocessed nickel ore to support this plan.

During 2019 the Company carried out an extensive exploration and development program on Cyclops and achieved successful nickel results with its drilling and bench-scale scoping tests for processing of materials.

Drilling identified significant horizons of nickel mineralization and bench-scale scoping tests returned positive results for processing of this nickel rich material.

The recovery percentages form the bench-scale test program are set out below (for further information, please refer to the Company’s press release of October 28, 2019):

Sample Nickel (%) Cobalt (%) Iron (%)
Limonite 99.26 98.82 97.77
Low Iron Transition 99.75 97.03 99.22
Saprolite 99.77 >99.9 99.74

 

Selected elevated nickel drill results are provided below from the Company’s shallow drilling program (for further information, please refer to the Company’s press releases of March 5, April 1, April 23, June 13, June 20 and September 10, 2019):

Intersection length (metres from surface) Nickel (%) Cobalt (%)
7.0 2.15% 0.03%
4.0 1.96% 0.04%
2.0 2.00% 0.01%
2.0 1.91% 0.05%

 

2020 will see continued and consistent development in Pacific Rim Cobalt’s strategy as the company continues to set ambitious milestones with the goal of becoming a leading international player in the EV battery metal sector and creating significant long-term shareholder value.

This includes preparations to commission and operate the company’s pilot plant in Canada, which will contain an integrated circuit to produce high-purity nickel and cobalt strip solutions to develop battery-grade nickel and cobalt.

The results of the pilot plant will then be used to establish the design criteria for the subsequent demonstration plant in Indonesia, which will produce nickel and cobalt products suitable to meet market specifications. As well as demonstrating Pacific Rim Cobalt’s ability to produce a product within market specifications, this will also be used to establish the design criteria for the company’s commercial-scale plant.

Pacific Rim Cobalt’s world-class management team includes Ranjeet Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Bolt Metals Corp. (OTCQB: PCRCF), closed Friday's trading session at $0.12, off by 2.439%, on 60,769 volume with 19 trades. The average volume for the last 3 months is 50,058 and the stock's 52-week low/high is $0.079999998/$0.355599999.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) today announced that an interview with its president Will Ralston will air on The RedChip Money Report television program. According to the update, the exclusive interview will feature Ralston as he provides insight into the company's rapidly growing solar business for residential and commercial customers. To view the interview segment, visit http://cnw.fm/h95QC. To view the full press release, visit http://cnw.fm/3W1jA.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Friday's trading session at $0.005, off by 7.4074%, on 9,488,596 volume with 189 trades. The average volume for the last 3 months is 4,627,054 and the stock's 52-week low/high is $0.004/$0.021999999.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that the company, its production facilities and medical clinics are all continuing to react to COVID-19 with adjustments to internal business practices consistent with the guidelines of public health authorities. Among other highlights from the update, the company reported that it is encouraging all to suspend travel, work from home when possible, and increase the use of personal protective equipment to lessen the risk of COVID-19 exposure and spread. To view the full press release, visit http://cnw.fm/1WrP8

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Friday's trading session at $0.125, up 5.2189%, on 90,953 volume with 58 trades. The average volume for the last 3 months is 232,531 and the stock's 52-week low/high is $0.109999999/$0.83249998.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders, Inc. (OTC: NBDR), today announced that the Company's subsidiary, MediDent Supplies, has begun expedited Air Freight shipments of medical equipment and supplies into its operations center in Phoenix, Arizona with the first shipment scheduled to land within 24 hours. 

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Friday's trading session at $0.02, up 48.1481%, on 17,072,471 volume with 837 trades. The average volume for the last 3 months is 783,412 and the stock's 52-week low/high is $0.008299999/$0.0581.

Recent News

chart

LiveWire Ergogenics Inc. (OTC: LVVV)

The QualityStocks Daily Newsletter would like to spotlight LiveWire Ergogenics Inc. (LVVV).

LiveWire Ergogenics (OTC: LVVV), a company focused on acquiring special purpose real estate properties conducive to discovering and developing cannabinoid products for the health and wellness industry to improve life performance, today released a letter to shareholders. In the letter, LiveWire Ergogenics Chairman and CEO Bill Hodson discussed the forecast for 2020 as a year of significant growth in total cannabis sales and provided updates surrounding the company’s Estrella Ranch “Estate Grown Weedery,” as well as other corporate initiatives. To view the full press release, visit http://cnw.fm/8HhCG

LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.

During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:

PODs and Distribution in Coachella, California

For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.

Estrella Ranch in Paso Robles, California

Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.

 

The Paso Robles Nursery

LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.

LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.

GHC Ventures Subsidiary

GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.

GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.

Research Partnerships

LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.

LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.

7X Pure™ Dosing and Verification System

LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.

The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.

The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.

Acquisitions & Operations

To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.

Market Opportunity

Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.

The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.

Business Model

LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.

Management Team

LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.

Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.

As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.

Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.

Advisory Board

Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.

Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.

Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.

Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.

LiveWire Ergogenics Inc. (OTC: LVVV), closed Friday's trading session at $0.0035, up 12.9032%, on 445,087 volume with 18 trades. The average volume for the last 3 months is 691,700 and the stock's 52-week low/high is $0.002099999/$0.0317.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Thursday announced that Peter Horvath is stepping down as chief executive officer and as a member of the Board of Directors, effective immediately. Green Growth’s current chief operating officer Randy Whitaker will serve as interim chief executive officer. In addition, the company provided an update regarding COVID-19. To view the full press release, visit http://cnw.fm/Sxcn4

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Friday's trading session at $0.0605, off by 12.9496%, on 1,400,585 volume with 344 trades. The average volume for the last 3 months is 659,654 and the stock's 52-week low/high is $0.05/$4.48999977.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Friday's trading session at $0.50, up 100%, on 1,200 volume with 6 trades. The average volume for the last 3 months is 618 and the stock's 52-week low/high is $0.0982/$3.00.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Friday's trading session at $0.236, up 38.8235%, on 411 volume with 4 trades. The average volume for the last 3 months is 15,421 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.152212, up 12.7496%, on 1,407,568 volume with 483 trades. The average volume for the last 3 months is 515,426 and the stock's 52-week low/high is $0.101000003/$1.75.

Recent News

chart

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Friday's trading session at $0.19042, up 4.2255%, on 190,763 volume with 50 trades. The average volume for the last 3 months is 143,012 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.